Torthaí cuardaigh - Hong Liu‐Seifert

  • 1 - 9 toradh as 9 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

    Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs de réir Hong Liu‐Seifert, David H. Adams, Bruce J. Kinon

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee

    A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee de réir Amy S. Chappell, D. Desaiah, Hong Liu‐Seifert, Shuyu Zhang, Vladimir Skljarevski, Yuri Belenkov, Jacques P. Brown

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Assessing quality of life in Alzheimer's disease: Implications for clinical trials

    Assessing quality of life in Alzheimer's disease: Implications for clinical trials de réir Kristin Kahle‐Wrobleski, Wenyu Ye, David Henley, Ann Marie Hake, Eric Siemers, Yun‐Fei Chen, Hong Liu‐Seifert

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Delayed‐start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years

    Delayed‐start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years de réir Hong Liu‐Seifert, Eric Siemers, Karen C. Holdridge, Scott W. Andersen, Ilya Lipkovich, Christopher Carlson, Gopalan Sethuraman, S. Hoog, Roza Hayduk, Rachelle S. Doody, Paul Aisen

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease

    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease de réir Hong Liu‐Seifert, Eric Siemers, Karen Price, Baoguang Han, Katherine J. Selzler, David Henley, Karen Sundell, Paul Aisen, Jeffrey L. Cummings, Joel Raskin, Richard C. Mohs

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

    Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients de réir Eric Siemers, Karen Sundell, Christopher Carlson, Michael Case, Gopalan Sethuraman, Hong Liu‐Seifert, Sherie A. Dowsett, Michael J. Pontecorvo, Robert A. Dean, Ronald B. DeMattos

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

    A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, ope... de réir Philip J. Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu‐Seifert, Paul Emery, Sreekumar Pillai, Philip Helliwell

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease de réir Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

    Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease de réir Lawrence S. Honig, Bruno Vellas, Mark Woodward, Merçé Boada, Roger Bullock, Michael Borrie, Klaus Häger, Niels Andreasen, Elio Scarpini, Hong Liu‐Seifert, Michael Case, Robert A. Dean, Ann Marie Hake, Karen Sundell, Vicki Poole Hoffmann, Christopher Carlson, Rashna Khanna, Mark A. Mintun, Ronald B. DeMattos, Katherine J. Selzler, Eric Siemers

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: